Menu

HIV AIDS

Scientists close in on AIDS vaccine blueprint

AIDS HIV ribbon_Reuters_Mar 4 2013.jpg

Nurses stand to form a Red Ribbon while holding a banner to mark World AIDS Day at a medical school in Yangzhou, Jiangsu province.REUTERS/China Daily

Researchers said Wednesday they have mapped an "arms race" in the human body between the AIDS virus and powerful antibodies that fight it off—the latest of several recent scientific advances accelerating the pursuit of a vaccine.

In a study published in the journal Nature, researchers showed how a virus that had recently infected an African patient battled powerful proteins called "broadly neutralizing antibodies," which few HIV patients have but which can target thousands of strains of HIV.

The virus and antibodies changed and evolved time and time again in the patient, trying to outwit one another.

The fascinating back-and-forth one-upmanship between the virus and the antibodies, which the researchers documented by examining more than three years' worth of blood samples from the patient, is akin to an "arms race," said Barton Haynes, a leader of the research and director of the Duke Human Vaccine Institute at Duke University.

Following that battle allowed them to pinpoint how the powerful antibodies develop and evolve—a question that scientists have been seeking to answer for years.

The research could help in the development of a vaccine that would mimic the antibodies' evolution and ward off HIV, the virus that causes AIDS, Dr. Haynes said. "We have a full blueprint now for how those antibodies were made," he said.

The quest for an AIDS vaccine is one of the most vexing in all of science because unlike other viruses, HIV mutates frequently—even over the course of a week in a single patient—to outmaneuver antibodies that fight against it.

About 34 million people were living with HIV in 2011, and 1.7 million died, according to the Joint United Nations Programme on HIV/AIDS. About 2.5 million were newly infected with HIV that year.

Click for more from The Wall Street Journal.

From Around the Web